DRUGREBOOT.AI
DEAD

Serial Number

99262228

Owner

ThinkBio.ai., Inc.

Attorney

MICHAEL LEE EVANS

First Use Date

May 1, 2025

Filing Date

Jul 1, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DRUGREBOOT.AI Trademark

Serial Number: 99262228

DRUGREBOOT.AI is a trademark filed by ThinkBio.ai., Inc. on July 1, 2025. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ThinkBio.ai., Inc.

3602 Inland Empire Blvd.,v Suite C-200
Ontario, CA 91764

Entity Type: 03

Trademark Details

Filing Date

July 1, 2025

Registration Date

Not Registered

First Use Anywhere

May 1, 2025

First Use in Commerce

May 1, 2025

Goods & Services

International Class 42: Providing medical and scientific research information in the field of clinical trials. Drugreboot.ai is software service that analyzes a failed trial to discover molecular features associated with drug response. Drugreboot.ai combines the molecular features with the patient's clinical attributes to predict the reasons why the drug failed in the clinical trial and provides additional analysis using disease models identifies strategies for salvaging the therapy. The software provides the user with information on clinical trials failures and next steps, the main service here is that of a software services that assists those conducting clinical trials in pivoting to other uses Providing medical and scientific research information in the field of clinical trials.

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Aug 13, 2026 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Aug 13, 2026 ABN2
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Apr 6, 2026 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Apr 6, 2026 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Apr 6, 2026 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 11, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 11, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2026 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2026 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 11, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 9, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 9, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 9, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2025 TROA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 25, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 1, 2025 MAFR
NEW APPLICATION ENTERED
Jul 1, 2025 NWAP